Krane Funds Advisors LLC acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 7,082 shares of the company's stock, valued at approximately $342,000.
Other institutional investors have also modified their holdings of the company. Operose Advisors LLC bought a new stake in shares of Tempus AI during the 4th quarter worth approximately $25,000. Cherry Tree Wealth Management LLC bought a new stake in Tempus AI during the 1st quarter valued at $31,000. Farther Finance Advisors LLC purchased a new position in shares of Tempus AI in the 4th quarter valued at $34,000. Prestige Wealth Management Group LLC increased its holdings in shares of Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after acquiring an additional 965 shares during the period. Finally, Continuum Advisory LLC purchased a new position in shares of Tempus AI in the 1st quarter valued at $39,000. 24.22% of the stock is owned by institutional investors.
Insider Activity at Tempus AI
In other news, EVP Erik Phelps sold 51,317 shares of the company's stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $72.56, for a total value of $3,723,561.52. Following the completion of the sale, the executive vice president directly owned 97,779 shares in the company, valued at $7,094,844.24. This represents a 34.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jennifer A. Doudna sold 625 shares of the company's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $62.52, for a total value of $39,075.00. Following the completion of the sale, the director owned 26,554 shares of the company's stock, valued at $1,660,156.08. This trade represents a 2.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 607,522 shares of company stock worth $41,300,238 in the last quarter. Corporate insiders own 27.60% of the company's stock.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on TEM. Guggenheim lifted their price target on Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a report on Monday, June 30th. Bank of America boosted their target price on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. Morgan Stanley boosted their target price on Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Needham & Company LLC restated a "buy" rating and set a $70.00 target price on shares of Tempus AI in a research note on Wednesday, May 7th. Finally, BTIG Research initiated coverage on Tempus AI in a research note on Monday, April 21st. They set a "buy" rating and a $60.00 target price on the stock. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $63.67.
Check Out Our Latest Analysis on Tempus AI
Tempus AI Price Performance
NASDAQ TEM traded up $1.47 during trading hours on Friday, reaching $60.65. The company's stock had a trading volume of 6,389,112 shares, compared to its average volume of 7,421,123. The firm has a market capitalization of $10.50 billion and a price-to-earnings ratio of -7.78. Tempus AI, Inc. has a 1-year low of $30.81 and a 1-year high of $91.45. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.71 and a quick ratio of 1.56. The company's 50-day moving average is $62.53 and its two-hundred day moving average is $54.12.
Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The company had revenue of $255.74 million during the quarter, compared to analysts' expectations of $248.13 million. The business's revenue was up 75.4% compared to the same quarter last year. On average, equities analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current year.
Tempus AI Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access